Novan (NOVN) News Today → The only AI company to buy (From Porter & Company) (Ad) Free NOVN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative February 27, 2024 | wsj.comNovartis AGFebruary 16, 2024 | morningstar.comNovartis AG Registered SharesOctober 31, 2023 | morningstar.comNovartis AG Registered Shares NOVNSeptember 8, 2023 | bizjournals.comNovan reaches deals to sell assets in bankruptcy caseAugust 8, 2023 | msn.comFirm Retention Summary: NovanAugust 3, 2023 | msn.comNovan (NOVN) Price Target Increased by 43.52% to 15.81July 17, 2023 | marketwatch.comNovan Shares Hit 52-Week Low After Bankruptcy DeclarationJuly 17, 2023 | marketbeat.comTrading was temporarily halted for "NOVN" at 08:07 AM with a stated reason of "News pending."June 1, 2023 | bizjournals.comNovan cuts 50% of its workforce to extend runwayJune 1, 2023 | msn.comNovan drops 13%, will reduce workforce by 50%May 31, 2023 | markets.businessinsider.comNovan To "Sharpen" Focus, Resources On Berdazimer GelMay 31, 2023 | finance.yahoo.comNovan Focuses Strategic Direction and Announces RestructuringMay 31, 2023 | marketbeat.comTrading was temporarily halted for "NOVN" at 04:05 PM with a stated reason of "News pending."May 21, 2023 | fool.comNovan (NASDAQ: NOVN)May 17, 2023 | msn.comOppenheimer Maintains Novan (NOVN) Outperform RecommendationMay 16, 2023 | finance.yahoo.comNOVN: Counting Down to PDUFAMay 15, 2023 | finanznachrichten.deNovan, Inc.: Novan Reports First Quarter 2023 Financial Results and Provides Corporate UpdateMay 15, 2023 | markets.businessinsider.comNovan earnings: here's what Wall Street expectsMay 12, 2023 | msn.comEarnings Preview: NovanMay 12, 2023 | msn.comNovan Q1 2023 Earnings PreviewApril 20, 2023 | finance.yahoo.comNovan to Host Analyst and Investor Event: A Discussion of Molluscum’s Unmet Need with Pediatric Dermatologist Jeffrey Sugarman, MD, PhDApril 3, 2023 | msn.comNovan's Return On Capital Employed OverviewMarch 23, 2023 | finance.yahoo.comNovan to Report Full Year 2022 Financial Results on March 30, 2023March 7, 2023 | finance.yahoo.comFDA Accepts Novan’s NDA for Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum with a PDUFA Goal Date of January 5, 2024October 19, 2022 | reuters.comJPMorgan names Qian as Southeast Asia equity capital markets chief - ReutersOctober 14, 2022 | finance.yahoo.comNovan and EPI Health, a Novan Company, Announce Abstracts Accepted for Poster Presentation at the 42nd Annual Fall Clinical Dermatology Conference® - Yahoo FinanceOctober 14, 2022 | globenewswire.comNovan and EPI Health, a Novan Company, Announce Abstracts Accepted for Poster Presentation at the 42nd Annual Fall Clinical Dermatology Conference - GlobeNewswireOctober 14, 2022 | finance.yahoo.comNovan and EPI Health, a Novan Company, Announce Abstracts Accepted for Poster Presentation at the 42nd Annual Fall Clinical Dermatology Conference®October 6, 2022 | finance.yahoo.comGlobal Acne Treatment Market (2022 Edition)– Analysis By Treatment, Treatment Modality, End-Users, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2023-2028) - Yahoo FinanceOctober 3, 2022 | finance.yahoo.comWorldwide Acne Treatment Industry to 2027 - Focus on Retinoids, Antibiotics, Hormonal Drugs, Anti-Inflammatory Drugs and Chemical Peels - Yahoo FinanceSeptember 22, 2022 | globenewswire.comOutlook on the Acne Treatment Global Market, to 2027 - Rising Public Knowledge of Cosmetic Acne Treatments is Driving Growth - GlobeNewswireSeptember 15, 2022 | streetinsider.comEPI Health, a Novan Company, and MC2 Therapeutics Present WYNZORA® (calcipotriene and betamethasone dipropionate) Cream, 0.005%/0.064% Subgroup Data Analysis at Skin of Color Update 2022 Conference - StreetInsider.comSeptember 15, 2022 | benzinga.comNovan (NASDAQ:NOVN) – Novan Announces That EPI Health, A Novan Company, And MC2 Therapeutics Presented Da - BenzingaSeptember 15, 2022 | globenewswire.comEPI Health, a Novan Company, and MC2 Therapeutics Present - GlobeNewswireSeptember 5, 2022 | reuters.comNOVN.OQ - Novan Inc | Stock Price & Latest News | ReutersAugust 30, 2022 | finance.yahoo.comGenital Warts Market Size to Register Subsequent Growth by 2032 as Key Players Such as Verrica Pharmaceuticals, Tamir Biotechnology, Novan Inc., and others are Looking for Opportunities | DelveInsight - Yahoo FinanceAugust 28, 2022 | reuters.comNOVN.A - Novan Inc | Stock Price & Latest News | ReutersAugust 17, 2022 | benzinga.comNOVN: EPI Revenue Trends Are Strong - BenzingaAugust 13, 2022 | greenwichtime.comNovan: Q2 Earnings Snapshot - Greenwich TimeAugust 12, 2022 | finance.yahoo.comNovan Reports Second Quarter 2022 Financial Results and Provides Corporate Update - Yahoo FinanceAugust 11, 2022 | benzinga.comPreparing and Aligning Your Biotech Organization for Commercial Success, Upcoming Webinar Hosted by Xtalk - BenzingaAugust 11, 2022 | globenewswire.comNovan Reports Second Quarter 2022 Financial Results and Provides Corporate Update - GlobeNewswireAugust 10, 2022 | seekingalpha.comNovan Q2 2022 Earnings Preview (NASDAQ:NOVN) - Seeking AlphaJuly 21, 2022 | bizjournals.comNovan phase 3 trial results published in JAMA amid FDA push - Triangle Business Journal - The Business JournalsJuly 19, 2022 | finance.yahoo.comGlobal Acne Treatment Market, By Therapeutic Class, By Formulation, By Type, By Acne Type, By Distribution Channel, By Region, Competition Forecast & Opportunities, 2027 - Yahoo FinanceJuly 19, 2022 | seekingalpha.comNovan stock gains; Oppenheimer begins coverage at Outperform on SB206's market potential - Seeking AlphaJuly 19, 2022 | globenewswire.comNovan Satisfies $16.5 Million Outstanding Promissory Note - GlobeNewswireJuly 13, 2022 | finance.yahoo.comNovan Announces Publication of Positive Results from Pivotal Phase 3 Study of Berdazimer Gel, 10.3% (SB206) in Patients with Molluscum Contagiosum in JAMA Dermatology - Yahoo FinanceJuly 13, 2022 | benzinga.comNovan Announces Publication Of Results From Pivotal Phase 3 Study Of Berdazimer Gel, 10.3% (SB206) In Patients With Molluscum Contagiosum In JAMA Dermatology - BenzingaJuly 13, 2022 | prnewswire.comNovan Announces Publication of Positive Results from Pivotal Phase 3 Study of Berdazimer Gel, 10.3% (SB206) in Patients with Molluscum Contagiosum in JAMA Dermatology - PR Newswire Get Novan News Delivered to You Automatically Sign up to receive the latest news and ratings for NOVN and its competitors with MarketBeat's FREE daily newsletter. Email Address LEAKED: Jeff Bezos' $330 Million Gamble (Ad)Did you know that 3 simple words are disrupting a $62.7 billion market? "Blood Brain Barrier" Seems innocent enough. Here's how you could invest alongside them >>> NOVN Media Mentions By Week NOVN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NOVN News Sentiment▼0.000.78▲Average Medical News Sentiment NOVN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NOVN Articles This Week▼00▲NOVN Articles Average Week Get Novan News Delivered to You Automatically Sign up to receive the latest news and ratings for NOVN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Agile Therapeutics News Today CNS Pharmaceuticals News Today Biophytis News Today Aridis Pharmaceuticals News Today Altamira Therapeutics News Today Aravive News Today Onconetix News Today Quoin Pharmaceuticals News Today Longeveron News Today Biodexa Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NOVN) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novan, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
